—

22NW, LP

Q4 2025 13F Holdings

  • Location
    seattle, WA
  • Num holdings

    20

  • Value ($000)

    $237,584

  • Date Filed
    02/13/2026
  • Form type
    13F-HR
  • CIK
    0001694297
  • All SEC filings
  • Note
    Holdings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q4 2025 to
Select Quarter
Issuer Name
Class
CUSIP
VALUE
%
Shares
Principal
Option Type
A
ANEB

ANEBULO PHARMACEUTICALS INC

COM
034569103
$84.76M
36 %

15,467,300

F
FSTR

FOSTER L B CO

COM
350060109
$32.1M
14 %

1,191,046

L
LDE

LIFECORE BIOMEDICAL INC

COM
514766104
$23.03M
10 %

1,254

---

NEKTAR THERAPEUTICS

COM NEW
640268306
$14M
6 %

331,115

R
RGNX

REGENXBIO INC

COM
75901B107
$13.3M
6 %

923,679

M
MLYS

MINERALYS THERAPEUTICS INC

COM
603170101
$13M
6 %

358,325

---

STONERIDGE INC

COM
86183P102
$12.7M
5 %

2,192,764

M
MEC

MAYVILLE ENGR CO INC

COM
578605107
$7.76M
3 %

414,280

C
CULP

CULP INC

COM
230215105
$6.62M
3 %

1,859,061

P
PFX

PHENIXFIN CORP

COM
71742W103
$5.21M
2 %

117,885

Rows Per Page
10
  • 5
  • 10
  • 20
  • 30
  • 50
  • 100
1 - 10 of 20